The National Science Foundation's (NSF) Tokyo Office periodically receives and disseminates reports on research developments in Japan that are related to the Foundation's mission. NSF-sponsored researchers currently working in Japan prepare many of these reports. These reports present information for use by NSF program managers and policy makers; they are not statements of NSF policy.
Special Scientific Report #00-07 (September 01, 2000)
Ms.
Noemi Custodia, a graduate student in Biology Department at Boston University,
prepared the following report. Ms.
Custodia was a participant in the 2000
Monbusho Summer Program sponsored by NSF and the Ministry of Education,
Science, Sports and Culture (Monbusho).
Dr. Makoto Osada of the Education
and Research Center of Marine Bio-resources at Tohoku University, hosted Ms.
Custodia. Ms. Custodia can be reached via email at: custodia@bio.bu.edu
My
laboratory at Boston University (Dr. Ian Callard, Biology Department) is
interested in the study of environmental endocrine disrupters.
Specifically, we are interested in substances that mimic or modify the
action of estrogen. Among the
biomarkers for endocrine disrupters, the following are receiving special
attention in our lab: vitellogenin induction, cytochrome P450 aromatase
(P450aro) induction, and metallothionein induction.
We are developing the use of the fresh water mussel, Elliptio complanata and the worm, C. elegans, as animal models for low-level exposure of PCBS, heavy
metals, and xenobiotic contamination of fresh water lakes and ponds.
However, in these two species, as in other invertebrates and vertebrates,
vitellogenin is synthesized but its regulation is not understood.
As
part of a study using the fresh water mussel as a sentinel species for
xenobiotic impact, we have identified the yolk proteins and are currently
investigating their regulation (Won and Callard, 1999 Biol. of Rep., 60:1, 293). Our
interest on the study of the yolk proteins regulation in bivalves, led us to
contact Dr. Osada at Dr. Kijima's laboratory (Integrated Aquatic Biology, Tohoku
University, Japan). Dr. Osada is
also interested in studying the regulation of yolk proteins in another bivalve
species, the scallop Patinopecten
yessoensis. He provided us with
an antibody against scallop vitellogenin. Using
this antibody, our group in Boston was able to demonstrate the estrogen
induction on the expression of vitellogenin in the gonads of the fresh water
mussel. In further studies, we
cloned and sequenced a CDNA fragment from the gonad of the fresh water mussel,
which shows high homology to some members of the steroid receptor superfamily
(PR, GR, AR, and ER). Dr. Osada's
previous studies also demonstrated a profile of vitellogenin induction on
scallops treated with estrogens similar to the fresh water mussel.
In addition, his studies have also demonstrated the presence of an
estrogen-like molecule in the gonad of the scallop (Matsumoto et al., 1997.
Comp. Biochem Physiol.).
At
this point, our labs are interested in identify steroidgenic enzymes and steroid
receptor-like molecules in the fresh water mussel and the scallop.
My work during the summer in Dr. Kijima's laboratory under Dr. Osada's
direct supervision had two objectives: (a) identify a steroidgenic enzyme that
contributes to the regulation of vitellogenin gene expression in the ovary of
the scallop; (b) gain meaningful information about the physiology of
reproduction of bivalves.
My
main research consisted of screening a scallop ovary CDNA library using a human
placental P450 aromatase antibody. Initially
we were able to obtain eight positive clones.
However after DNA sequencing analysis we selected only one clone as a
candidate for P450aro. Further, identification of the nucleotide sequence of this
clone was not possible because this clone is not a still-length CDNA.
It is a fragment of a CDNA, which contains the 3'- end region (including
part of the untranslated region and the poly (A) tail).
This made this clone difficult to characterize as a P450aro since the
homology among P450aro at this portion of the 3'-end region is very low.
Nevertheless, the homology of this clone to the sequence of other P450aro
is around 40%. Future experiments
involve the amplification of the 5'-end of this P450aro candidate in order to
obtain enough information to completely characterize it.
Due
to the limit of time, I was not able to further continue with this research
project. However, before I left Dr.
Kijima's lab I designed a group of specific primers to the P450aro candidate
clone sequence that will be used in the 5'- end RACE. I also discussed with Dr. Osada different aspects of this
ongoing research project and how it would assist into a larger one, which is
expandable into his work, at Tohoku University and our work, at Boston
University.
On
a personal note, even though, the results remain inconclusive, the knowledge
gained is very meaningful. The
interaction with the people from this lab has helped me to expand my vision on
research. I learned how to target
the same technical problems that I face in United State from another point of
view. I also enjoyed very much the
graduate student life style of Japan. After
this experience, I am strongly considering a postdoc in Japan.
Thanks to Dr. Kijima, Dr. Osada, and the Monbusho program for this
experience.